Patients and Doctors share insights

November 2, 2019

From the desk of Jorge D Faccinetti, cofounder – One word describes this conference: FUN!  The National and International Canadian conference this past September in Toronto, Canada, was not only a good time, but it was

Positive news for new Cushing’s drug

September 23, 2019

In a press release, Strongbridge Biopharma announced comprehensive positive results of their Phase 3 SONICS study of RECORLEVTM (levoketoconazole) for the potential treatment of endogenous Cushing’s syndrome. The results were published online in The Lancet

Developing a new drug for acromegaly

August 20, 2019

As we reported earlier this year, the acromegaly new drug development world has seen very exciting activity. Several studies are in the pipeline for oral therapies.  Today, San Diego California based Crinetics Pharmaceuticals announced a new

Why do adenomas recur?

July 22, 2019
Today's podcast is about silent Corticotropic adenomas and the recurrence rate of these tumors vs. all pituitary adenomas.  Dr. Blevins weighs into a recent paper and current research to discuss why adenomas recur and, importantly,